Recent Quarter Total Invested
$23.38 M
Recent Quarter Institutional Ownership Percentage
13.05%
Total Invested of Last Quarter
$14.94 M
Ownership Percentage of Last Quarter
13.34%
DiaMedica Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| COOPERMAN LEON G | 11/14/2024 | 1.51 M | $6.33 M | 7.98% | 3.54% |
| FIRST MANHATTAN CO. LLC. | 11/14/2024 | 839,081 | $3.52 M | 0.00% | 1.96% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 11/14/2024 | 482,614 | $2.02 M | 0.00% | 1.13% |
| BLEICHROEDER LP | 11/13/2024 | 382,317 | $1.60 M | 0.00% | 0.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 306,958 | $1.29 M | 29.58% | 0.72% |
| LPL FINANCIAL LLC | 11/08/2024 | 140,500 | $588,695 | 702.86% | 0.33% |
| MORGAN STANLEY | 11/14/2024 | 110,016 | $460,967 | 27.63% | 0.26% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 107,790 | $451,639 | 100.00% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 101,450 | $425,076 | 133.90% | 0.24% |
| STATE STREET CORP | 11/14/2024 | 68,729 | $287,975 | 0.00% | 0.16% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 52,089 | $218,253 | 100.00% | 0.12% |
| RONALD BLUE TRUST, INC. | 10/17/2024 | 44,247 | $130,529 | 100.00% | 0.10% |
| CATALYST FINANCIAL PARTNERS LLC | 10/28/2024 | 38,457 | $161,135 | 0.00% | 0.09% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 33,690 | $141,161 | 100.00% | 0.08% |
| JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 26,000 | $108,940 | 100.00% | 0.06% |
| STONEBRIDGE CAPITAL ADVISORS LLC | 11/14/2024 | 17,500 | $73,325 | -12.50% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 16,959 | $71,058 | 0.00% | 0.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 13,251 | $55,522 | 0.00% | 0.03% |
| UBS GROUP AG | 11/14/2024 | 12,739 | $53,376 | 100.00% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2024 | 11,831 | $49,572 | 40.63% | 0.03% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 10/18/2024 | 11,520 | $48,269 | 100.00% | 0.03% |
| MAGNOLIA CAPITAL ADVISORS LLC | 10/30/2024 | 10,000 | $41.90 M | 0.00% | 0.02% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 9,498 | $39,797 | 100.00% | 0.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 8,200 | $34,358 | 530.77% | 0.02% |
| MASSMUTUAL TRUST CO FSB/ADV | 10/02/2024 | 4,824 | $20,213 | 0.00% | 0.01% |
| US BANCORP \DE\ | 10/28/2024 | 4,335 | $18,164 | 0.00% | 0.01% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 3,662 | $15,000 | 100.00% | 0.01% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 3,263 | $13,672 | 100.00% | 0.01% |
| NAPLES MONEY MANAGEMENT LLC | 11/12/2024 | 2,068 | $8,665 | -30.56% | 0.00% |
| TD WATERHOUSE CANADA INC. | 11/12/2024 | 1,070 | $4,449 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1,055 | $4,420 | -48.66% | 0.00% |
| LEGEND FINANCIAL ADVISORS, INC. | 10/18/2024 | 1,000 | $4,190 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2024 | 805 | $3,000 | -23.77% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 213 | $892 | 16.39% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 200 | $838 | -80.00% | 0.00% |
| CORNERSTONE PLANNING GROUP LLC | 11/05/2024 | 80 | $346 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 27 | $113 | 100.00% | 0.00% |
| TORONTO DOMINION BANK | 11/18/2024 | 0 | $0 | -100.00% | 0.00% |
| ARISTIDES CAPITAL LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/15/2024 | 0 | $0 | -100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
DiaMedica Therapeutics Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of DMAC shares?
During the previous two years, 41 institutional investors and hedge funds held shares of DiaMedica Therapeutics Inc.. The most heavily invested institutionals were:
COOPERMAN LEON G: 1.51 M
FIRST MANHATTAN CO. LLC.: 839,081
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE: 482,614
Bleichroeder LP: 382,317
GEODE CAPITAL MANAGEMENT, LLC: 306,958
LPL Financial LLC: 140,500
-
What percentage of DiaMedica Therapeutics Inc. stock is owned by institutional investors?
13.05% of DiaMedica Therapeutics Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at DMAC ?
Institutional investors have bought a total of 4.65 M shares in the last 24 months. This purchase volume represents approximately $21.97 M in transactions.